About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,828 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,828 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5081-5100 of 10,828 trials

TerminatedINcrease Of VAgal TonE in CHFThe purpose of the INOVATE-HF study is to demonstrate the long-term safety and efficacy of vagus nerve stimulation with the CardioFit® system for the treatment of subjects with…NCT01303718·Birmingham, Alabama and 86 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedA Study to Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid TumorsThe purpose of this study is to evaluate MEDI0562 in combination with immune therapeutic agents in adult subjects with select advanced solid tumors.NCT02705482·Santa Monica, California and 11 others

CompletedDopamine and Insulin ResistanceObese individuals have fewer striatal dopamine type 2 receptors (DRD2) than normal weight individuals.NCT00802204·Nashville, Tennessee

CompletedEfficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type PsoriasisThis was a multicenter, randomized, vehicle-controlled, double-blind parallel group study to evaluate the efficacy and safety of CD 2027 Oily Spray applied twice daily for 8 weeks…NCT00763555·Fridley, Minnesota and 5 others

CompletedA Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung CancerThis is a study of the drug perifosine that consists of 2 parts.NCT00399789·Tucson, Arizona and 20 others

TerminatedSafety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the ToenailsThe objectives of this study are to assess the safety of NAB001 for topical treatment of mild to moderate distal onychomycosis of the toenails over 52 weeks and to compare the…NCT01208168·Phoenix, Arkansas and 23 others

RecruitingCRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple MyelomaThis is a Phase 1 study to evaluate the safety of CB-011 (the study treatment), an allogeneic chimeric antigen receptor (CAR-T) cell therapy that targets the B cell maturation…NCT05722418·Birmingham, Alabama and 15 others

CompletedA Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue SarcomaThe main purpose of this study is to evaluate the safety and efficacy of two anti-cancer drugs (gemcitabine and docetaxel) with and without the study drug known as olaratumab in…NCT02659020·Santa Monica, California and 47 others

CompletedStudy of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast CancerThe purpose of this trial is to explore the clinical utility of the three investigational agents in HR+, HER2- breast cancer.NCT02088684·Birmingham, Alabama and 10 others

RecruitingPivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaThis Phase 3 study in adult participants with newly diagnosed low-risk APL will evaluate the efficacy, safety, and PK of an oral capsule formulation of ATO, in combination with…NCT07504458·Birmingham, Alabama and 32 others

CompletedStudy to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic SteatohepatitisThe primary objective of this study is to evaluate the safety and tolerability of firsocostat in adults with nonalcoholic steatohepatitis (NASH).NCT02856555·Coronado, California and 35 others

CompletedCombination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00005026·Birmingham, Alabama and 46 others

CompletedBYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast CancerThis phase I trial studies the side effects and best dose of the PI3K inhibitor BYL719 when given together with letrozole in treating patients with hormone receptor-positive…NCT01791478·Boston, Massachusetts and 1 other

RecruitingA Phase 1 Study of BHV-1530 in Advanced Solid TumorsThis is a Phase 1, first in human (FIH), Open-Label, Dose Escalation, Dose Expansion and Dose Optimization Study of BHV-1530 as Monotherapy and in Combination with Other…NCT06874335·Newport Beach, California and 16 others

CompletedNovel Experimental COVID-19 Therapies Affecting Host ResponseThe overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19.NCT04924660·Birmingham, Alabama and 50 others

CompletedThe Effect of Higher Protein Dosing in Critically Ill PatientsThe investigator will investigate the effects of higher protein/amino acid dosing (≥2.2 g/kg/d) vs usual protein/amino acid dosing (≤1.2 g/kg/d) on clinical outcomes in…NCT03160547·Phoenix, Arizona and 85 others

CompletedA Study to Evaluate Corrected QT Interval and Drug-Drug Interaction of Trastuzumab on Carboplatin in the Presence of Docetaxel in Patients With HER2-Positive Metastatic or Locally Advanced Inoperable CancerThis Phase Ib, multicenter, single-arm, open-label study is designed to evaluate the effect of trastuzumab on QTcF interval and to characterize the effects of trastuzumab on…NCT00927589·Scottsdale, Arizona and 19 others

TerminatedA Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial CarcinomaThe study will evaluate the clinical activity of PD-(L)1 Checkpoint Inhibitor regimens in combination with the investigational agent sitravatinib in patients with advanced or…NCT03606174·Tucson, Arizona and 35 others

CompletedA Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)This is a Phase 1b, open-label, non-randomized, multicenter, dose-finding study evaluating venetoclax in combination with azacitidine in participants with treatment-naïve…NCT02942290·Tucson, Arizona and 36 others

CompletedA Study to Test Combination Treatments in People With Advanced Renal Cell CarcinomaThe purpose of this study is to test the effectiveness and safety of various nivolumab combinations compared to nivolumab and ipilimumab in participants with advanced kidney cancerNCT02996110·New Haven, Connecticut and 31 others

PreviousPage 255 of 542Next

Diabetes

in Nashville

Heart Diseasein Nashville